Navigation Links
Strains of antibiotic-resistant 'Staph' bacteria show seasonal preference; Children at higher risk in summer
Date:2/27/2013

Strains of potentially deadly, antibiotic-resistant Staphylococcus aureus bacteria show seasonal infection preferences, putting children at greater risk in summer and seniors at greater risk in winter, according to results of a new nationwide study led by a Johns Hopkins researcher.

It's unclear why these seasonal and age preferences for infection with methicillin-resistant Staph aureus (MRSA) occur, says Eili Klein, Ph.D., lead author on the study and a researcher at the Johns Hopkins Center for Advanced Modeling in the Social, Behavioral and Health Sciences.

But he says that increased use of antibiotics in the winter may be one of the reasons. The winter strain that infects seniors at a greater rate is generally acquired in the hospital and resistant to more antibiotics. On the other hand, the summer strain of MRSA, which is seen with growing frequency in children, is largely a community-transmitted strain that is resistant to fewer antibiotics.

"Overprescribing antibiotics is not harmless," Klein notes. "Inappropriate use of these drugs to treat influenza and other respiratory infections is driving resistance throughout the community, increasing the probability that children will contract untreatable infections."

In fact, the study found that while MRSA strains exhibit a seasonal pattern, overall MRSA infections have not decreased over the last five years, despite efforts to control their spread.

A report on the study, which used sophisticated statistical models to analyze national data for 2005-2009, appears today in the online issue of the American Journal of Epidemiology.

As the researchers report, hospitalizations from infections tied to MRSA doubled in the United States between 1999 and 2005. The ballooning infection numbers were propelled by MRSA acquired in community settings, not hospital or other health care settings, as had been the case prior to 1999.

Specifically, the study found that a strain of MRSA typically seen in community settings is more likely to cause infection during the summer months, peaking around July/August. The authors' data analysis showed children were most at risk of becoming infected with this strain, typically from a skin or soft tissue wound or ailment.

In fact, in examining data for one year 2008 the research team found that 74 percent of those under the age of 20 who developed an infection with MRSA had a community-associated MRSA infection.

Meanwhile, the health care-associated MRSA strain, which is typically seen in hospitals, nursing homes and other health care settings, was found to be most prevalent in the winter months, peaking in February/March. Patients aged 65 or older are more likely to acquire a MRSA infection from this strain.

"Our analysis ... shows significant seasonality of MRSA infections and the rate at which they affect different age groups," write the authors of the report titled "The changing epidemiology of methicillin-resistant Staphylococcus aureus in the United States: A national observational study."

Klein said additional research on seasonal patterns of MRSA infections and drug resistance may help with developing new treatment guidelines, prescription practices and infection control programs.


'/>"/>

Contact: Mark Guidera
mguider1@jhmi.edu
410-502-9405
Johns Hopkins Medicine
Source:Eurekalert

Related medicine news :

1. Some Whooping Cough Strains Now Outsmarting Vaccine
2. Infection With 2 HIV Strains Slows Disease Progression
3. Einstein awarded $6 million grant to develop new TB vaccine against drug-resistant strains
4. Test links strains of common parasite to severe illness in US newborns
5. Synthetic corkscrew peptide kills antibiotic-resistant Gram-negative bacteria
6. Antibiotic-Resistant Gonorrhea Spreading: WHO
7. NIH scientists discover promising target to block Staphylococcus infection
8. African Chimps Carry Drug-Resistant, Human-Linked Staph
9. Chronic exposure to staph bacteria may be risk factor for lupus, Mayo study finds
10. Genomes show how Staph bacteria gain resistance to last-line drug
11. New discoveries linking gut bacteria with cholesterol metabolism give hope for the future
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... New York, NY (PRWEB) , ... December 07, ... ... measurable amounts of the drug in their bodies, a researcher at the Icahn ... the journal Pediatric Research. , The study found that when young children are ...
(Date:12/7/2016)... ... December 07, 2016 , ... In the early morning of ... an emergency medical call when he lost control of his patrol car. The vehicle ... his vehicle, he was transported to Atlanta Medical Center, where he later succumbed to ...
(Date:12/7/2016)... ... December 07, 2016 , ... They are musicians and librarians, ... wives, brothers and fathers, from New England and around the nation. What do they ... are brought together in a beautiful and compelling new photographic exhibit debuting Friday, December ...
(Date:12/7/2016)... ... 07, 2016 , ... Augustine Insurance Agency, a locally owned ... owners in the greater Dallas metropolitan area, is announcing a charity event that ... Established in 2009 by active police professionals in the Dallas region, the Dallas ...
(Date:12/7/2016)... , ... December 07, 2016 , ... Sharon Kleyne, host ... Climate Change and Your Health on Voice of America, declared on her radio program ... attention to the fact that when these bullies attack leaders in corporate America, they ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... 2016 According to the latest ... Market Study on Multiplex Detection Immunoassay: North America to ... global multiplex detection immunoassay market is expected to witness a CAGR ... ...      (Logo: http://photos.prnewswire.com/prnh/20161114/438683LOGO) ...
(Date:12/7/2016)... 2016 The global  blood ... of USD 3.9 billion by 2024, based on ... The growth of the market is attributed to ... advancements by the market players. Demand for blood ... donation, rising awareness about transfusion-transmitted diseases, and technological ...
(Date:12/6/2016)... 6, 2016  Alopexx Oncology, LLC announced data from ... fusion protein (immunocytokine) composed of interleukin-2 and a CD20-targeting ... on B cells as Rituxan and maintains the activities ... also involved in tumor targeting, engagement of the immune ... results of the study (abstract #95954) were presented at ...
Breaking Medicine Technology: